These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
754 related articles for article (PubMed ID: 32087064)
1. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma. Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064 [TBL] [Abstract][Full Text] [Related]
2. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma. Li H; Liu H; Fu H; Li J; Xu L; Wang G; Wu H Front Immunol; 2021; 12():648812. PubMed ID: 34122408 [TBL] [Abstract][Full Text] [Related]
3. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589 [TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Gong W; Zhang S; Tian X; Chen W; He Y; Chen L; Ding T; Ren P; Shi L; Wu Q; Sun Y; Chen L; Guo H Hepatol Int; 2024 Aug; 18(4):1310-1325. PubMed ID: 38767772 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review. Hu L; Li X; Yang C; Zhou B; Du C; Jiang N Front Immunol; 2024; 15():1390938. PubMed ID: 38887293 [TBL] [Abstract][Full Text] [Related]
6. Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma. Wen S; Chen Y; Hu C; Du X; Xia J; Wang X; Zhu W; Wang Q; Zhu M; Chen Y; Shen B Front Immunol; 2021; 12():788640. PubMed ID: 35095864 [TBL] [Abstract][Full Text] [Related]
7. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer. Xin S; Wen S; He P; Zhao Y; Zhao H Front Immunol; 2024; 15():1423775. PubMed ID: 39192984 [TBL] [Abstract][Full Text] [Related]
8. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma. Zhang T; Lei X; Jia W; Li J; Nie Y; Mao Z; Wang Y; Tao K; Song W Cancer Med; 2023 Feb; 12(3):3068-3078. PubMed ID: 36082777 [TBL] [Abstract][Full Text] [Related]
9. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma. Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284 [TBL] [Abstract][Full Text] [Related]
10. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513 [TBL] [Abstract][Full Text] [Related]
11. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures. Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048 [TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756 [TBL] [Abstract][Full Text] [Related]
13. Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response. Ahmed A; Halama N Anticancer Res; 2020 Nov; 40(11):6367-6373. PubMed ID: 33109574 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective. Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W Front Immunol; 2022; 13():1007426. PubMed ID: 36189217 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer. Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757 [TBL] [Abstract][Full Text] [Related]
16. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma. Shen YC; Hsu CL; Jeng YM; Ho MC; Ho CM; Yeh CP; Yeh CY; Hsu MC; Hu RH; Cheng AL J Hepatol; 2020 Mar; 72(3):489-497. PubMed ID: 31634533 [TBL] [Abstract][Full Text] [Related]
17. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma. Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124 [TBL] [Abstract][Full Text] [Related]
18. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma. Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116 [TBL] [Abstract][Full Text] [Related]
19. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540 [TBL] [Abstract][Full Text] [Related]
20. The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer. Yu JS; Huang WB; Zhang YH; Chen J; Li J; Fu HF; Wei ZW; He YL Neoplasma; 2022 Jul; 69(4):886-898. PubMed ID: 35603954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]